Paradromics Gets FDA Approval to Trial Its Brain Implant in People
Briefly

Paradromics Gets FDA Approval to Trial Its Brain Implant in People
"Paradromics is one of several companies-which include Neuralink, Synchron, Precision Neuroscience, and Cognixion-working on technology to control computers and other devices using brain waves. Known as brain-computer interfaces, or BCIs, these systems capture brain signals associated with movement intention and translate them into commands. The Paradromics study is slated to begin early next year and include two individuals. After collecting data on the first two participants for a year, the company plans to ask the FDA to expand the study to include more volunteers."
""It's reasonable to think that someone will be communicating at 60 words per minute and be able to really sustain the conversation," says Matt Angle, Paradromics' CEO and founder, referring to a rate achieved by previous BCI trials led by academic groups. Normal speaking speed is between 120 and 150 words per minute. BCIs for speech restoration do not read a person's inner thoughts."
Paradromics received FDA approval to begin an early-stage human trial of a brain implant intended to restore synthesized speech and text communication for people with severe motor impairment. The initial study will enroll two participants early next year and gather a year of data before seeking expansion to more volunteers. Paradromics joins several companies developing brain-computer interfaces that translate motor cortex signals tied to movement intention into device commands. Trials aim to decode attempted speech by asking users to try saying sentences aloud so the system can learn corresponding brain patterns and generate synthesized or recorded-voice output.
Read at WIRED
Unable to calculate read time
[
|
]